Earnings Scheduled For November 9, 2021
Companies Reporting Before The Bell
• Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter.
• KT (NYSE:KT) is projected to report earnings for its third quarter.
How Bad Are OncoCyte Corporation Common Stock’s Earnings? | Return On Capital Employed
Benzinga Pro data, OncoCyte Corporation Common Stock (AMEX:OCX) reported Q2 sales of $2.03 million. Earnings fell to a loss of $13.57 million, resulting in a 19.44% decrease from last quarter.
Oncocyte To Present New Data On DetermaIO From NeoTRIPaPDL1 Trial In Oral Presentation From Late-Breaking Abstract At ESMO 2021 Sept. 20
Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear insights that inform critical decisions in the diagnosis, treatment,
Oncocyte Launches Real-World Evidence (RWE) Registry To Evaluate Biomarker Impact On Early-Stage Lung Cancer Treatment Decisions And Outcomes
Predictive Assay for Decision Making in Adjuvant Therapy (PADMA) Registry to enroll more than 1,000 patients at 25 major hospitals treating lung cancer in the United States
77 Biggest Movers From Yesterday
Gainers
Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to engage in cryptocurrency mining.
54 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) jumped 64.2% to $2.0850 after the company announced it is expanding its blockchain business to engage in cryptocurrency mining.
Mid-Morning Market Update: Markets Down; US Producer Prices Rise 1% In July
Following the market opening Thursday, the Dow traded down 0.27% to 35,390.70 while the NASDAQ fell 0.29% to 14,722.22. The S&P also fell, dropping 0.17% to 4,440.19.
66 Biggest Movers From Yesterday
Gainers
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) shares jumped 50.5% to close at $20.74 on Wednesday. The company, last month, priced its IPO at $11 per share.